SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: billkirn who wrote (5020)7/30/1998 9:27:00 PM
From: scaram(o)uche  Read Replies (1) of 6136
 
Bill and others:

I got a copy of the Franklin Fund annual report, 4/30/98. No record of AGPH held in the Global Health Care Fund, also managed by Von Emster. In the Biotech Discovery Fund, there was no record of shares sold short, and there were 60,000 shares of common held long (aggregate value $2,040,000). It was one of the larger holdings, but it didn't quite make the top ten.

So, since you got the inside scoop from his wife, one might assume that he sold all 60K shares and then some.

His short positions at 4/30 were BGEN, Biora AB (ADR), ELN, ICOS, PDLI, SANG and TKTX.

His taste is OK.... he has some great longs, and some really lame ones. Big long positions in great picks (e.g., NXCO) and in crash stocks (e.g., TXB). So..... his long portfolio looks like his short portfolio.... big winners, big losers.

Rick
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext